Skip to main content
Top
Published in: Infection 4/2016

01-08-2016 | Original Paper

In vitro susceptibility of methicillin-resistant and methicillin-susceptible strains of Staphylococcus aureus to two different cold atmospheric plasma sources

Authors: Matthias Napp, Georg Daeschlein, Sebastian von Podewils, Peter Hinz, Steffen Emmert, Hermann Haase, Romy Spitzmueller, Denis Gümbel, Richard Kasch, Michael Jünger

Published in: Infection | Issue 4/2016

Login to get access

Abstract

Background

Staphylococcus aureus may be the most important wound pathogen and causative for most of surgical site infections. As many anti-staphylococcal drugs are useless because of resistance, novel antimicrobial strategies are strongly needed and may be provided by cold atmospheric plasma (CP), which is being currently investigated for antiseptic efficacy.

Methods

To test the antimicrobial properties of CP against Staphylococcus aureus, 168 methicillin-susceptible isolates (MSSA) and 50 methicillin-resistant isolates (MRSA) were treated with two technically different plasma sources [an atmospheric pressure plasma jet (APPJ) and a dielectric barrier discharge plasma (DBD)] in vitro.

Results

CP treatment allowed a reproducible and significant growth reduction of MRSA and MSSA. However, MRSA was significantly less susceptible to treatment with DBD than was MSSA, while no difference between MRSA and MSSA was found using APPJ.

Conclusions

As the initial physical antiseptic on skin, CP may be suitable for rapid decolonization of microbial pathogens in vivo. Each device must undergo validated efficacy testing prior to clinical application, as device related differences may occur.
Footnotes
1
R Development Core Team (2009). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://​www.​R-project.​org.
 
Literature
2.
go back to reference U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. 2013;5–113. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. 2013;5–113.
3.
go back to reference Köck R, Schaumburg F, Mellmann A, et al. Livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) as causes of human infection and colonization in Germany. PLoS ONE. 2013;8:e55040.CrossRefPubMedPubMedCentral Köck R, Schaumburg F, Mellmann A, et al. Livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) as causes of human infection and colonization in Germany. PLoS ONE. 2013;8:e55040.CrossRefPubMedPubMedCentral
4.
go back to reference Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53–9.CrossRefPubMed Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53–9.CrossRefPubMed
5.
go back to reference Wijaya L, Hsu LY, Kurup A. Community-associated methicillin-resistant Staphylococcus aureus: overview and local situation. Ann Acad Med Singapore. 2006;35:479–86.PubMed Wijaya L, Hsu LY, Kurup A. Community-associated methicillin-resistant Staphylococcus aureus: overview and local situation. Ann Acad Med Singapore. 2006;35:479–86.PubMed
6.
go back to reference Pasternack MS. Decontamination strategies for MRSA-colonized patients. Curr Infect Dis Rep. 2008;10:385–6.CrossRefPubMed Pasternack MS. Decontamination strategies for MRSA-colonized patients. Curr Infect Dis Rep. 2008;10:385–6.CrossRefPubMed
7.
go back to reference Brehmer F, Haenssle HA, Daeschlein G, et al. Alleviation of chronic venous leg ulcers with a hand-held dielectric barrier discharge plasma generator (PlasmaDerm® VU-2010): results of a monocentric, two-armed, open, prospective, randomized, and controlled trial (NCT01415622). J Eur Acad Dermatol Venereol. 2014. doi:10.1111/jdv.12490.PubMed Brehmer F, Haenssle HA, Daeschlein G, et al. Alleviation of chronic venous leg ulcers with a hand-held dielectric barrier discharge plasma generator (PlasmaDerm® VU-2010): results of a monocentric, two-armed, open, prospective, randomized, and controlled trial (NCT01415622). J Eur Acad Dermatol Venereol. 2014. doi:10.​1111/​jdv.​12490.PubMed
8.
go back to reference Isbary G, Morfill G, Schmidt HU, et al. A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol. 2010;163:78–82.PubMed Isbary G, Morfill G, Schmidt HU, et al. A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol. 2010;163:78–82.PubMed
9.
go back to reference Isbary G, Heinlin J, Shimizu T, et al. Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol. 2012;167:404–10.CrossRefPubMed Isbary G, Heinlin J, Shimizu T, et al. Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol. 2012;167:404–10.CrossRefPubMed
10.
go back to reference Brandenburg R, Ehlbeck J, Stieber M, et al. Antimicrobial treatment of heat sensitive materials by means of atmospheric pressure Rf-driven plasma jet. Contrib Plasma Phys. 2007;47:72–9.CrossRef Brandenburg R, Ehlbeck J, Stieber M, et al. Antimicrobial treatment of heat sensitive materials by means of atmospheric pressure Rf-driven plasma jet. Contrib Plasma Phys. 2007;47:72–9.CrossRef
11.
go back to reference Fridman G, Brooks AD, Balasubramanian M, et al. Comparison of direct and indirect effects of non-thermal atmospheric-pressure plasma on bacteria. Plasma Process Polym. 2007;4:370–5.CrossRef Fridman G, Brooks AD, Balasubramanian M, et al. Comparison of direct and indirect effects of non-thermal atmospheric-pressure plasma on bacteria. Plasma Process Polym. 2007;4:370–5.CrossRef
12.
go back to reference Daeschlein G, von Woedtke T, Kindel E, et al. Antibacterial activity of an atmospheric pressure plasma jet against relevant wound pathogens in vitro on a simulated wound environment. Plasma Process Polym. 2010;7:224–30.CrossRef Daeschlein G, von Woedtke T, Kindel E, et al. Antibacterial activity of an atmospheric pressure plasma jet against relevant wound pathogens in vitro on a simulated wound environment. Plasma Process Polym. 2010;7:224–30.CrossRef
13.
go back to reference Daeschlein G, Scholz S, von Woedtke T, et al. In vitro killing of clinical fungal strains by low-temperature atmospheric-pressure plasma jet. IEEE Trans Plasma Sci. 2011;39:815–21.CrossRef Daeschlein G, Scholz S, von Woedtke T, et al. In vitro killing of clinical fungal strains by low-temperature atmospheric-pressure plasma jet. IEEE Trans Plasma Sci. 2011;39:815–21.CrossRef
14.
go back to reference Daeschlein G, Napp M, von Podewils S, et al. In vitro susceptibility of multidrug resistant skin and wound pathogens against low temperature atmospheric pressure plasma jet (APPJ) and dielectric barrier discharge plasma (DBD). Plasma Process Polym. 2014;11:175–83.CrossRef Daeschlein G, Napp M, von Podewils S, et al. In vitro susceptibility of multidrug resistant skin and wound pathogens against low temperature atmospheric pressure plasma jet (APPJ) and dielectric barrier discharge plasma (DBD). Plasma Process Polym. 2014;11:175–83.CrossRef
15.
go back to reference Fridman G, Friedman G, Gutsol A, et al. Applied plasma medicine. Plasma Process Polym. 2008;5:503–33.CrossRef Fridman G, Friedman G, Gutsol A, et al. Applied plasma medicine. Plasma Process Polym. 2008;5:503–33.CrossRef
16.
go back to reference Shashurin A, Keidar M, Bronnikov S, et al. Living tissue under treatment of cold plasma atmospheric jet. Appl Phys Lett. 2008;93:181501.CrossRef Shashurin A, Keidar M, Bronnikov S, et al. Living tissue under treatment of cold plasma atmospheric jet. Appl Phys Lett. 2008;93:181501.CrossRef
17.
go back to reference Kalghatgi SU, Fridman G, Fridman A, et al. Non-thermal dielectric barrier discharge plasma treatment of endothelial cells. Conf Proc IEEE Eng Med Biol Soc. 2008;2008:3578–81.PubMed Kalghatgi SU, Fridman G, Fridman A, et al. Non-thermal dielectric barrier discharge plasma treatment of endothelial cells. Conf Proc IEEE Eng Med Biol Soc. 2008;2008:3578–81.PubMed
18.
go back to reference Daeschlein G, Darm K, Majunke S, et al. In vivo monitoring of atmospheric pressure plasma jet (APPJ) skin therapy by confocal laserscan microscopy (CLSM). In: Paper presented at the second international conference on plasma medicine, San Antonio, TX, 2009. Daeschlein G, Darm K, Majunke S, et al. In vivo monitoring of atmospheric pressure plasma jet (APPJ) skin therapy by confocal laserscan microscopy (CLSM). In: Paper presented at the second international conference on plasma medicine, San Antonio, TX, 2009.
19.
go back to reference Lademann J, Richter H, Alborova A, et al. Risk assessment of the application of a plasma jet in dermatology. J Biomed Opt. 2009;14:054025.CrossRefPubMed Lademann J, Richter H, Alborova A, et al. Risk assessment of the application of a plasma jet in dermatology. J Biomed Opt. 2009;14:054025.CrossRefPubMed
20.
go back to reference Lademann O, Richter H, Patzelt A, et al. Application of a plasma-jet for skin antisepsis: analysis of the thermal action of the plasma by laser scanning microscopy. Laser Phys Lett. 2010;7:458–62.CrossRef Lademann O, Richter H, Patzelt A, et al. Application of a plasma-jet for skin antisepsis: analysis of the thermal action of the plasma by laser scanning microscopy. Laser Phys Lett. 2010;7:458–62.CrossRef
21.
go back to reference Daeschlein G, Scholz S, Ahmed R, et al. Cold plasma is well-tolerated and does not disturb skin barrier or reduce skin moisture. J Dtsch Dermatol Ges. 2012;10:509–15.PubMed Daeschlein G, Scholz S, Ahmed R, et al. Cold plasma is well-tolerated and does not disturb skin barrier or reduce skin moisture. J Dtsch Dermatol Ges. 2012;10:509–15.PubMed
22.
go back to reference Heinlin J, Morfill G, Landthaler M, et al. Plasma medicine: possible applications in dermatology. J Dtsch Dermatol Ges. 2010;8:968–76.PubMed Heinlin J, Morfill G, Landthaler M, et al. Plasma medicine: possible applications in dermatology. J Dtsch Dermatol Ges. 2010;8:968–76.PubMed
23.
go back to reference O’Connor N, Cahill O, Daniels S, et al. Cold atmospheric pressure plasma and decontamination. Can it contribute to preventing hospital-acquired infections? J Hosp Infect. 2014;88:59–65.CrossRefPubMed O’Connor N, Cahill O, Daniels S, et al. Cold atmospheric pressure plasma and decontamination. Can it contribute to preventing hospital-acquired infections? J Hosp Infect. 2014;88:59–65.CrossRefPubMed
24.
go back to reference Mai-Prochnow A, Murphy AB, McLean KM, et al. Atmospheric pressure plasmas: infection control and bacterial responses. Int J Antimicrob Agents. 2014;43:508–17.CrossRefPubMed Mai-Prochnow A, Murphy AB, McLean KM, et al. Atmospheric pressure plasmas: infection control and bacterial responses. Int J Antimicrob Agents. 2014;43:508–17.CrossRefPubMed
25.
go back to reference Bowler PG, Davies BJ. The microbiology of infected and noninfected leg ulcers. Int J Dermatol. 1999;38:573–8.CrossRefPubMed Bowler PG, Davies BJ. The microbiology of infected and noninfected leg ulcers. Int J Dermatol. 1999;38:573–8.CrossRefPubMed
26.
go back to reference Meyer V, Kerk N, Mellmann A, et al. MRSA eradication in dermatologic outpatients—theory and practice. J Dtsch Dermatol Ges. 2012;10:186–96.PubMed Meyer V, Kerk N, Mellmann A, et al. MRSA eradication in dermatologic outpatients—theory and practice. J Dtsch Dermatol Ges. 2012;10:186–96.PubMed
27.
go back to reference Jockenhöfer F, Gollnick H, Herberger K, et al. Bacteriological pathogen spectrum of chronic leg ulcers: results of a multicenter trial in dermatologic wound care centers differentiated by regions. J Dtsch Dermatol Ges. 2013;11:1057–63.PubMed Jockenhöfer F, Gollnick H, Herberger K, et al. Bacteriological pathogen spectrum of chronic leg ulcers: results of a multicenter trial in dermatologic wound care centers differentiated by regions. J Dtsch Dermatol Ges. 2013;11:1057–63.PubMed
28.
go back to reference Ulmer M, Lademann J, Patzelt A, et al. New strategies for preoperative skin antisepsis. Skin Pharmacol Physiol. 2014;27:283–92.CrossRefPubMed Ulmer M, Lademann J, Patzelt A, et al. New strategies for preoperative skin antisepsis. Skin Pharmacol Physiol. 2014;27:283–92.CrossRefPubMed
29.
go back to reference Maisch T, Shimizu T, Li YF, et al. Decolonisation of MRSA, S. aureus and E. coli by cold-atmospheric plasma using a porcine skin model in vitro. PLoS ONE. 2012;7:e34610.CrossRefPubMedPubMedCentral Maisch T, Shimizu T, Li YF, et al. Decolonisation of MRSA, S. aureus and E. coli by cold-atmospheric plasma using a porcine skin model in vitro. PLoS ONE. 2012;7:e34610.CrossRefPubMedPubMedCentral
30.
go back to reference Weltmann KD, Kindel E, Brandenburg R, et al. Atmospheric pressure plasma jet for medical therapy: plasma parameters and risk estimation. Contrib Plasma Phys. 2009;49:631–40.CrossRef Weltmann KD, Kindel E, Brandenburg R, et al. Atmospheric pressure plasma jet for medical therapy: plasma parameters and risk estimation. Contrib Plasma Phys. 2009;49:631–40.CrossRef
31.
go back to reference Kuchenbecker M, Bibinov N, Kaemling A, et al. Characterization of DBD plasma source for biomedical applications. J Phys D Appl Phys. 2009;42:045212.CrossRef Kuchenbecker M, Bibinov N, Kaemling A, et al. Characterization of DBD plasma source for biomedical applications. J Phys D Appl Phys. 2009;42:045212.CrossRef
32.
go back to reference Helmke A, Hoffmeister D, Mertens N, et al. The acidification of lipid film surfaces by non-thermal DBD at atmospheric pressure in air. New J Phys. 2009;11:115025.CrossRef Helmke A, Hoffmeister D, Mertens N, et al. The acidification of lipid film surfaces by non-thermal DBD at atmospheric pressure in air. New J Phys. 2009;11:115025.CrossRef
33.
go back to reference Thomas L, Maillard JY, Lambert RJ, Russell AD. Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a “residual” concentration. J Hosp Infect. 2000;46:297–303.CrossRefPubMed Thomas L, Maillard JY, Lambert RJ, Russell AD. Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a “residual” concentration. J Hosp Infect. 2000;46:297–303.CrossRefPubMed
34.
go back to reference Kawai M, Yamada S, Ishidoshiro A, et al. Cell-wall thickness: possible mechanism of acriflavine resistance in methicillin-resistant Staphylococcus aureus. J Med Microbiol. 2009;58:331–6.CrossRefPubMed Kawai M, Yamada S, Ishidoshiro A, et al. Cell-wall thickness: possible mechanism of acriflavine resistance in methicillin-resistant Staphylococcus aureus. J Med Microbiol. 2009;58:331–6.CrossRefPubMed
35.
go back to reference Daeschlein G, Scholz S, Arnold A, et al. In vitro susceptibility of important skin and wound pathogens against low temperature atmospheric pressure plasma jet (APPJ) and dielectric barrier discharge plasma (DBD). Plasma Process Polym. 2012;9:380–9.CrossRef Daeschlein G, Scholz S, Arnold A, et al. In vitro susceptibility of important skin and wound pathogens against low temperature atmospheric pressure plasma jet (APPJ) and dielectric barrier discharge plasma (DBD). Plasma Process Polym. 2012;9:380–9.CrossRef
36.
go back to reference Heinlin J, Zimmermann JL, Zeman F, et al. Randomized placebo-controlled human pilot study of cold atmospheric argon plasma on skin graft donor sites. Wound Rep Reg. 2013;21:800–7.CrossRef Heinlin J, Zimmermann JL, Zeman F, et al. Randomized placebo-controlled human pilot study of cold atmospheric argon plasma on skin graft donor sites. Wound Rep Reg. 2013;21:800–7.CrossRef
Metadata
Title
In vitro susceptibility of methicillin-resistant and methicillin-susceptible strains of Staphylococcus aureus to two different cold atmospheric plasma sources
Authors
Matthias Napp
Georg Daeschlein
Sebastian von Podewils
Peter Hinz
Steffen Emmert
Hermann Haase
Romy Spitzmueller
Denis Gümbel
Richard Kasch
Michael Jünger
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 4/2016
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0888-9

Other articles of this Issue 4/2016

Infection 4/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.